Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVPH | ZTS | TAK | UTHR | NBIX |
| Company | Reviva Pharmaceuticals Hldg Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.1700 | 163.24 | 14.92 | 304.22 | 108.45 |
| High | 1.2300 | 163.99 | 14.96 | 307.73 | 109.56 |
| Low | 1.1500 | 160.52 | 14.84 | 301.25 | 106.83 |
| Last | 1.1500 | 161.68 | 14.93 | 307.09 | 109.07 |
| Change | -0.0100 | -2.71 | +0.03 | +2.67 | +1.85 |
| % Change | -0.86% | -1.65% | +0.20% | +0.88% | +1.73% |
| Volume | 573,900 | 2,384,404 | 1,789,278 | 723,300 | 1,342,500 |
| 20-Day Average Volume | 1,228,040 | 4,120,150 | 1,578,760 | 631,990 | 1,407,665 |
| Previous Close | 1.1600 | 164.39 | 14.90 | 304.42 | 107.22 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4460 | 165.07 | 14.36 | 337.73 | 114.86 |
| 20-Day Raw Stochastic | 3.23% | 32.45% | 85.75% | 7.10% | 22.65% |
| 20-Day Relative Strength | 34.63% | 43.81% | 66.58% | 34.71% | 32.87% |
| Weighted Alpha | -63.15 | -9.19 | +8.24 | +13.71 | -26.51 |
| Today's Opinion | 24% Sell | 100% Sell | 56% Buy | 72% Sell | 56% Sell |
| Previous Opinion | 24% Sell | 96% Sell | 40% Buy | 72% Sell | 56% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 40% Sell | 24% Sell | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.88% since 03/05/25 | -3.19% since 03/05/25 | -0.73% since 03/05/25 | -1.25% since 03/05/25 | -4.20% since 03/05/25 |
| Low | 1.1200 on 03/10/25 | 160.52 on 03/12/25 | 14.83 on 03/11/25 | 301.25 on 03/12/25 | 105.18 on 03/11/25 |
| High | 1.3200 on 03/06/25 | 177.00 on 03/10/25 | 15.22 on 03/07/25 | 323.99 on 03/10/25 | 115.31 on 03/06/25 |
| 1-Month | |||||
| %Chg | -38.50% since 02/12/25 | -7.02% since 02/12/25 | +12.59% since 02/12/25 | -17.17% since 02/12/25 | -6.92% since 02/12/25 |
| Low | 1.1200 on 03/10/25 | 154.32 on 02/18/25 | 13.48 on 02/13/25 | 301.25 on 03/12/25 | 105.18 on 03/11/25 |
| High | 1.9000 on 02/13/25 | 177.00 on 03/10/25 | 15.22 on 03/07/25 | 383.51 on 02/19/25 | 122.37 on 02/21/25 |
| 3-Month | |||||
| %Chg | -58.48% since 12/12/24 | -9.60% since 12/12/24 | +11.00% since 12/12/24 | -15.08% since 12/12/24 | -13.98% since 12/12/24 |
| Low | 1.1200 on 03/10/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 301.25 on 03/12/25 | 105.18 on 03/11/25 |
| High | 2.9500 on 12/13/24 | 181.85 on 12/13/24 | 15.22 on 03/07/25 | 383.51 on 02/19/25 | 154.61 on 01/30/25 |
| 6-Month | |||||
| %Chg | +2.68% since 09/12/24 | -15.22% since 09/12/24 | +0.74% since 09/12/24 | -9.97% since 09/12/24 | -10.07% since 09/12/24 |
| Low | 0.8820 on 11/11/24 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 301.25 on 03/12/25 | 105.18 on 03/11/25 |
| High | 4.2800 on 12/09/24 | 200.33 on 09/19/24 | 15.22 on 03/07/25 | 417.82 on 11/08/24 | 154.61 on 01/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 38,792 | 73,612,528 | 47,410,296 | 13,672,109 | 10,690,264 |
| Shares Outstanding, K | 33,441 | 447,792 | 3,181,899 | 44,912 | 99,704 |
| Annual Sales | 0 | 9,256,000,000 | 29,419,960,000 | 2,877,400,000 | 2,355,300,000 |
| Annual Net Income | -39,260,000 | 2,486,000,000 | 994,060,000 | 1,195,100,000 | 341,300,000 |
| Last Quarter Sales | 0 | 2,317,000,000 | 7,511,170,000 | 735,900,000 | 627,700,000 |
| Last Quarter Net Income | -8,370,000 | 581,000,000 | 156,180,000 | 301,300,000 | 103,100,000 |
| 60-Month Beta | -0.09 | 0.94 | 0.46 | 0.64 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 11/14/24 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | 6.19 on 02/26/25 | 1.00 on 02/06/25 |
| Latest Earnings Date | 04/21/25 | 05/01/25 | 02/06/25 | 02/26/25 | 02/06/25 |
| Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.02 | 10.59 | 12.92 | 33.70 |